As up-regulation of BIRC5 (an apoptosis inhibitor/cell-cycle regulator) and FOXM1 (an oncogenic transcription factor) genes were identified in relapsed BCP-ALL, these genes can be introduced as biomarkers/indicators of poor prognosis. This evidence concerns the gene FOXM1 and acute lymphoblastic leukemia.